Literature DB >> 16793958

The androgen receptor CAG repeat modifies the impact of testosterone on insulin resistance in women with polycystic ovary syndrome.

Matthias Möhlig1, Annette Jürgens, Joachim Spranger, Kurt Hoffmann, Martin O Weickert, Hans W Schlösser, Thilo Schill, Georg Brabant, Andreas Schüring, Andreas F H Pfeiffer, Jörg Gromoll, Christof Schöfl.   

Abstract

OBJECTIVE: Hyperandrogenism is a central feature of the polycystic ovary syndrome (PCOS) and might worsen insulin resistance (IR) often seen in PCOS. Androgens act through the androgen receptor (AR). A polymorphic CAG repeat sequence within the AR gene was reported to modulate its transactivation activity. Therefore, we investigated a putative interaction between testosterone and the CAG repeat length polymorphism with respect to IR.
DESIGN: In 63 PCOS women with normal glucose tolerance free testosterone, the biallelic CAG repeat length and a multiplicative interaction term were investigated by multiple linear regression analysis for an association with IR as indicated by the homeostasis model assessment of IR (HOMA-IR).
RESULTS: Free testosterone was correlated with HOMA-IR. The impact of testosterone on HOMA-IR was modified by the AR CAG length as indicated by an interaction term. This interaction remained significant after adjustment for smoking, age and body mass index. While there was a positive association of free testosterone with HOMA-IR, the interaction term was inversely associated. The model, which explained 42.5% of the variation of HOMA-IR predicted that in carriers of short CAG lengths, an increase in testosterone increased IR. This effect attenuated with rising biallelic CAG length until it turns into the opposite at a CAG length longer than 23. The results were confirmed by using CIGMA as another measure of IR.
CONCLUSIONS: The association between testosterone and IR is modified by the CAG repeat polymorphism within the AR. Therefore, the evaluation of testosterone effects on IR seems to require consideration of the AR CAG repeat polymorphism in PCOS women.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16793958     DOI: 10.1530/eje.1.02195

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  13 in total

Review 1.  [Polycystic ovary syndrome. Prototype of a cardio-metabolic syndrome].

Authors:  D Heutling; H Schulz; H Randeva; C Dodt; H Lehnert
Journal:  Internist (Berl)       Date:  2007-02       Impact factor: 0.743

2.  Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model.

Authors:  M Kupreeva; A Diane; R Lehner; R Watts; M Ghosh; S Proctor; D Vine
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-08-28       Impact factor: 4.310

3.  Ethnic variation in allele distribution of the androgen receptor (AR) (CAG)n repeat.

Authors:  Christine M Ackerman; Lynn P Lowe; Hoon Lee; M Geoffrey Hayes; Alan R Dyer; Boyd E Metzger; William L Lowe; Margrit Urbanek
Journal:  J Androl       Date:  2011-05-19

Review 4.  Negative association between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome? A systematic review and meta-analysis.

Authors:  Rui Wang; Mark O Goodarzi; Ting Xiong; Di Wang; Ricardo Azziz; Hanwang Zhang
Journal:  Mol Hum Reprod       Date:  2012-06-12       Impact factor: 4.025

5.  Androgen receptor CAG repeat polymorphism and epigenetic influence among the south Indian women with Polycystic Ovary Syndrome.

Authors:  Shilpi Dasgupta; Pisapati V S Sirisha; Kudugunti Neelaveni; Kathragadda Anuradha; Alla G Reddy; Kumarasamy Thangaraj; B Mohan Reddy
Journal:  PLoS One       Date:  2010-08-26       Impact factor: 3.240

6.  Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome.

Authors:  Nissar A Shah; Heath J Antoine; Marita Pall; Kent D Taylor; Ricardo Azziz; Mark O Goodarzi
Journal:  J Clin Endocrinol Metab       Date:  2008-02-26       Impact factor: 5.958

7.  Role of androgen receptor CAG repeat polymorphism and X-inactivation in the manifestation of recurrent spontaneous abortions in Indian women.

Authors:  Meka Aruna; Shilpi Dasgupta; Pisapati V S Sirisha; Sadaranga Andal Bhaskar; Surapaneni Tarakeswari; Lalji Singh; B Mohan Reddy
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240

8.  Androgen receptor CAG repeats length polymorphism and the risk of polycystic ovarian syndrome (PCOS).

Authors:  Singh Rajender; Silas Justin Carlus; Sandeep Kumar Bansal; Mahendra Pal Singh Negi; Mahendra Pratap Singh Negi; Nirmala Sadasivam; Muthusamy Narayanan Sadasivam; Kumarasamy Thangaraj
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

Review 9.  Genetic Variants Associated with Hyperandrogenemia in PCOS Pathophysiology.

Authors:  Roshan Dadachanji; Nuzhat Shaikh; Srabani Mukherjee
Journal:  Genet Res Int       Date:  2018-02-18

10.  The role of androgen receptor activity mediated by the CAG repeat polymorphism in the pathogenesis of PCOS.

Authors:  N Baculescu
Journal:  J Med Life       Date:  2013-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.